EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 4
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Asia Pacific

Takeda’s Entyvio beats AbbVie’s Humira in head-to-head UC study

Takeda's Entyvio outperformed AbbVie's Humira as an ulcerative colitis therapy, according a topline readout of a Phase 3b study by the Japanese pharma.The ...
13 March 2019 Asia Pacific | Europe | news | Regional News
Continue Reading →
news

New drug may stop sepsis from reaching major organs

Researchers discover a drug that has the potential to stop sepsis before the condition reaches major organs and becomes fatal. A new preclinical trial of a sep...
13 March 2019 news | North America | Regional News
Continue Reading →
news

New brain stimulation therapy is effective against depression

A new clinical trial has tested the ability of a little-studied, noninvasive brain stimulation technique to treat the symptoms of major depression. The results, so ...
13 March 2019 news | North America | Regional News
Continue Reading →
news

Ozempic® superior in lowering blood sugar and weight vs placebo, both in combination with SGLT-2 inhibitors

Novo Nordisk announced publication of results from the SUSTAIN 9 Phase 3b trial in The Lancet Diabetes & Endocrinology. The objective of this 30 week trial was t...
13 March 2019 news | North America | Regional News
Continue Reading →
Uncategorised

Szpital Specjalistyczny w Brzozowie, Poland, joins the global hospital network on Clinerion?s Patient Network Explorer platform.

Szpital Specjalistyczny w Brzozowie, (the Specialist Hospital in Brzoz?w), Poland, specializes in oncology, hematology and cardiology. The hospital has 485 beds and ...
13 March 2019 Uncategorised
Continue Reading →
Europe

Envigo launches PATHWAY, an optimized safety assessment solution to enable first-in-human clinical trials

11 March 2019, East Millstone, N.J. – Envigo, a leading provider of non-clinical contract research services and research models, announced today the launch of PATHWA...
13 March 2019 Europe | news | North America | Regional News
Continue Reading →
Europe

ERYTECH Presents Findings at European Red Cell Research Society Meeting

LYON, France and CAMBRIDGE, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical compa...
13 March 2019 Europe | news | Regional News
Continue Reading →
Europe

Aldevron Releases GMP-Grade SpyFi™ Cas9 Nuclease

Product is the result of a partnership with Integrated DNA Technologies, and provides clinical-stage clients with a critical raw material. FARGO, ND (March 12, 201...
13 March 2019 Europe | news | Regional News
Continue Reading →
Europe

ECCO 2019: Entyvio set to be most dominant drug in the UC landscape following VARSITY trial, says GlobalData

The results of the VARSITY trial, a head-to-head Phase IIIb double-blind, double-dummy, multicentre, active controlled study, that evaluates the efficacy and safety ...
13 March 2019 Europe | news | Regional News
Continue Reading →
Europe

Successful Phase 2 Clinical Trial Results with Novel Influenza Vaccine Validate SGS’s H3N2 Challenge Agent (A/Belgium)

Antwerp, Belgium March 12, 2019: SGS, a leading life-sciences, clinical and bioanalytical contract solutions provider, today welcomed the preliminary data from ...
13 March 2019 Europe | news | Regional News
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte